Recent Episodes
Fri. 7/6/12
Summer Reads
Fri. 7/6/12
Summer Reads
The Emily Rooney Show
We hear from area authors and literary insiders who reveal what’s on their summer reading lists. Plus we open up the phone lines and take your recommendations.
Thurs. 7/5/12
White House Burning
Thurs. 7/5/12
White House Burning
The Emily Rooney Show
We're joined by the authors of White House Burning, which argues that the national debt is eating away at America's future and that the consequences will be dire.
Wed. 7/4/12
Elizabeth The Queen: The Life Of A Modern Monarch
Wed. 7/4/12
Elizabeth The Queen: The Life Of A Modern Monarch
The Emily Rooney Show
In honor of Independence Day, we aired a special rewind episode about Elizabeth the Queen.
Wed. 7/4/12
Rebecca Eaton's 'Masterpiece'
Wed. 7/4/12
Rebecca Eaton's 'Masterpiece'
The Emily Rooney Show
A special rewind episode featuring Masterpiece Executive Producer Rebecca Eaton in the studio to discuss Downton Abbey's success and how she plans to stay on top.
Tues. 7/3/12
In The Studio With Dan Bern
Tues. 7/3/12
In The Studio With Dan Bern
The Emily Rooney Show
Our resident provocateur Steve Almond returns with an in-studio performance by Dan Bern and his backing band, Common Rotation.
Tues. 7/3/12
One On One With Tom Hamilton
Tues. 7/3/12
One On One With Tom Hamilton
The Emily Rooney Show
Tom Hamilton joins us – ahead of Aerosmith’s North American Tour – to explain what keeps him, Steven Tyler and the rest of the “Bad Boys From Boston” going after 40 years.
Latest Comments
Related Content
WAYH - Safeguarding The Safeguards Of Medicine
Ominous. That was the tone of conversation at a local biotech conference. With the purchase this month of Cambridge-based Genzyme by the French pharmaceutical giant Sanofi, local biotech executives are concerned that our smaller homegrown biotechs are increasing takeover targets by large multinational firms. While corporate ownership can bring funding and resources, scientist worry about losing the creative, entrepreneurial spirit that put Kendall Square on the biotech map. Christoph Westphal, chair of the venture capital firm, Longwood Founders Fund, joins us.














